Drug · DIN 02517698
LUMIFY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 5, 2022; first marketed July 5, 2022.
- Drug Identification Number (DIN)
- 02517698
- Company (DIN owner)
- Bausch & Lomb Inc.Rochester, New York, United States
- Schedule
- Non-prescription drugs
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Brimonidine S01EA05
- Class
- Human
- Record last updated
- December 12, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRIMONIDINE TARTRATE | 0.025 % | W/V |